Literature DB >> 35342814

Micro-embolic signal monitoring in stroke subtypes: A systematic review and meta-analysis of 58 studies.

Pachipala Sudheer1, Shubham Misra1, Manabesh Nath1, Pradeep Kumar1, Deepti Vibha1, M V Padma Srivastava1, Manjari Tripathi1, Rohit Bhatia1, Awadh Kishor Pandit1, Rajesh K Singh1.   

Abstract

Introduction: Micro-embolic signals (MESs) detected using transcranial Doppler (TCD) help in risk stratification in stroke patients. A systematic review and meta-analysis were performed to estimate the prevalence of MES and its association with stroke recurrence, functional outcome, and mortality in different stroke subtypes.
Methods: A comprehensive literature search was conducted before 26th January 2021 in PubMed, Embase, Google Scholar, Cochrane Library, and ClinicalTrials.gov. Studies were identified that used TCD to detect MES in stroke/TIA patients. Pooled prevalence and odds ratio (OR) along with 95% confidence interval (95% CI) were calculated for different outcome measures. The entire statistical analysis was conducted in R version 3.6.2. Findings: Fifty-eight studies involving 5123 patients (1329 MES+, 3794 MES-) were included in our meta-analysis. The pooled prevalence of MES among all acute stroke/TIA patients was 30% (95% CI 25-34%). The pooled prevalence adjusted after the trim-and-fill analysis among all acute stroke/TIA patients was 18% (95% CI 14-23%). The prevalence of MES was high among all stroke subtypes except in patients with small vessel disease (SVD). In patients with new-onset stroke/TIA, the presence of MES was associated with a high risk of recurrence of cerebral ischemia (OR 4.03; 95% CI 2.38-6.82). Although no significant association was observed for the presence of MES with increased mortality (OR 2.37; 95% CI 0.75-7.50) and poor functional outcome (OR 2.11; 95% CI 0.20-22.50) among patients with new-onset stroke/TIA, this could only be determined in a smaller sample size of 477 patients. Conclusions: Our meta-analysis showed a 30% prevalence of MES following acute stroke/TIA. The presence of MES increased the chance of recurrence of cerebral ischemia but was not associated with poor functional outcomes and mortality in the studied subgroup. © European Stroke Organisation 2021.

Entities:  

Keywords:  Micro-embolic signals; meta-analysis; prevalence; stroke; systematic review; transcranial Doppler

Year:  2021        PMID: 35342814      PMCID: PMC8948512          DOI: 10.1177/23969873211060819

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN: 2396-9873


  18 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

Review 2.  Transcranial Doppler Ultrasound Detection of Microemboli as a Predictor of Cerebral Events in Patients with Symptomatic and Asymptomatic Carotid Disease: A Systematic Review and Meta-Analysis.

Authors:  L M J Best; A C Webb; K S Gurusamy; S F Cheng; T Richards
Journal:  Eur J Vasc Endovasc Surg       Date:  2016-07-05       Impact factor: 7.069

3.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

4.  Clopidogrel versus dipyridamole in addition to aspirin in reducing embolization detected with ambulatory transcranial Doppler: a randomized trial.

Authors:  Alice King; Philip M W Bath; Hugh S Markus
Journal:  Stroke       Date:  2011-01-21       Impact factor: 7.914

5.  Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.

Authors:  Hugh S Markus; Dirk W Droste; Manfred Kaps; Vincent Larrue; Kennedy R Lees; Mario Siebler; E Bernd Ringelstein
Journal:  Circulation       Date:  2005-04-25       Impact factor: 29.690

6.  Statin Pretreatment and Microembolic Signals in Large Artery Atherosclerosis.

Authors:  Apostolos Safouris; Christos Krogias; Vijay K Sharma; Aristeidis H Katsanos; Simon Faissner; Andromachi Roussopoulou; Christina Zompola; Janina Kneiphof; Odysseas Kargiotis; Spyridon Deftereos; Georgios Giannopoulos; Nikos Triantafyllou; Konstantinos Voumvourakis; Konstantinos Vadikolias; Georgios Tsivgoulis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-27       Impact factor: 8.311

7.  Frequency of microemboli signal in stroke patients treated with low molecular weight heparin or aspirin.

Authors:  Qing Hao; Hui Meng Chang; Meng Cheong Wong; Ka Sing Wong; Christopher Chen
Journal:  J Neuroimaging       Date:  2008-12-16       Impact factor: 2.486

8.  Differentiation between different pathological cerebral embolic materials using transcranial Doppler in an in vitro model.

Authors:  H S Markus; M M Brown
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Statin Pretreatment and Microembolic Signals in Large Artery Atherosclerosis.

Authors:  Apostolos Safouris; Aristeidis H Katsanos; Antonios Kerasnoudis; Christos Krogias; Justin A Kinsella; Roman Sztajzel; Vaia Lambadiari; Spyridon Deftereos; Odysseas Kargiotis; Vijay K Sharma; Andrew M Demchuk; Maher Saqqur; Dominick J H McCabe; Georgios Tsivgoulis
Journal:  Stroke       Date:  2018-08       Impact factor: 7.914

10.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01
View more
  1 in total

1.  Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.

Authors:  Rolf R Diehl; Markus Kraemer; Mosche Pompsch; Roland Veltkamp
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.